Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study

Izumi Nasu, Masahiro Kondo, Ryuji Uozumi, Shinya Takada, Shuichi Nawata, Hirotoshi Iihara, Yohei Okumura, Masashi Takemoto, Kozo Mino, Tadanori Sasaki, Chiemi Hirose, Tohru Aomori, Rena Shimano, Ken Maeno, Satoshi Oizumi, Sojiro Kusumoto, Yasushi Ohno, Shinnosuke Ikemura, Daiya Takai, Azusa HaraHitoshi Kawazoe, Tomonori Nakamura

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study'. Together they form a unique fingerprint.

Medicine & Life Sciences